An international team led by scientists at the National Human Genome Research Institute (NHGRI) at the National Institutes of Health (NIH) has discovered a genetic "signature" that may help explain how malignant melanoma, a deadly form of skin cancer, can spread to other parts of the body.
Skin cancer is the most common type of cancer in the United States. An estimated 40 to 50 percent of Americans who live to age 65 will have skin cancer at least once. Basal cell carcinoma accounts for more than 90 percent of all skin cancers in the United States. Melanoma is the most serious cancer of the skin. In some parts of the world, especially among Western countries, the number of people who develop melanoma is increasing faster than any other cancer.
This issue contains a summary of the new genetic findings, information for patients on skin cancer and an National Cancer Institute treatment report that contains general information on skin cancer treatment. It includes information on cellular classification, stage information, basal cell carcinoma, squamous cell carcinoma, actinic keratosis, treatment option overview, basal cell carcinoma of the skin, squamous cell carcinoma of the skin and actinic keratosis.
A very interesting public health tool, FluAid is a test version of software created by programmers at the Centers for Disease Control and Prevention (CDC). It is designed to assist state and local level planners in preparing for the next influenza pandemic by providing estimates of potential impact specific to their locality. FluAid provides only a range of estimates of impact in terms of deaths, hospitalizations, and outpatients visits due to pandemic influenza.
Read about it and download your own copy from the CDC.
Finally, we have news that eleven Food and Drug Administration Commissioners -- who have served Presidents from Johnson to Clinton -- have written to members of Congress that the reimportation of prescription drugs poses grave risks for American patients. The reimportation issue is at the forefront of the news because there is legislation pending before a House/Senate conference committee that would overturn a consumer protection law enacted in 1988. The pending legislation would lower safety standards for imported prescription medicines. It would also greatly lower the price.
The articles in today's Vidyya are:
As always, we hope you enjoy the issue.